Cognitive and affective responses to acute stress influence pro-inflammatory cytokine reactivity, and peripheral cytokines (particularly interleukin-1 beta (IL-1b)), can act on the brain to promote depressive symptoms. It is unknown whether acute stress-induced changes in positive affect and cognitions (POS) and pro-inflammatory reactivity predict future depressive symptoms. We examined acute stress responses among women, to determine prospective predictors of depressive symptoms. Hypotheses: (1) Stressinduced decreases in POS will be associated with stress-related increases in circulating IL-1b. (2) Acute stress-induced decreases in POS and increases in IL-1b reactivity will predict increases in depressive symptoms 1 year later. Thirty-five post-menopausal women were exposed to acute stress with the Trier Social Stress Task (TSST) and provided blood samples under resting conditions and 30 min after the conclusion of the TSST, which were assayed for IL-1b. IL-1b reactivity was quantified as post minus pre-TSST. Failure to maintain POS was quantified as the decrease in POS during the TSST. Change in depressive symptoms from the study baseline to the following year was determined. Greater acute stress-induced declines in POS were significantly associated with increased IL-1b reactivity (p 6 .02), which significantly predicted increases in depressive symptoms over the following year (p < .01), controlling for age, body mass index, chronic stress, antidepressant use and baseline depressive symptoms. IL-1b reactivity was a significant mediator of the relationship between POS decline and future increases in depressive symptoms (p = .04). Difficulty maintaining positivity under stress and heightened pro-inflammatory reactivity may be markers and/or mechanisms of risk for future increases in depressive symptoms.
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Introduction
Depressive disorders are highly prevalent and place a substantial burden on society. They nearly double the risk of premature mortality (Barth et al., 2004; Cuijpers and Smit, 2002) , contribute to run-away health care budgets (Unutzer et al., 2009) , and cost employers billions of dollars each year in lost productivity (Stewart et al., 2003) . Moreover, the increased morbidity and economic costs are nearly as great for subclinical levels of depressive symptoms (Cuijpers et al., 2007; Cuijpers and Smit, 2002) . Despite the prevalence and importance of treating depressive symptomatology, one-third of patients with Major Depressive Disorder (MDD) fail to experience symptom remission following multiple courses of antidepressant treatment (Rush et al., 2006) . This suggests a need to better elucidate both the psychological and biological mechanisms underlying depressive symptoms, in order to develop novel approaches to treatment.
The ''Cytokine Hypothesis of Depression'' proposes that inflammation may be a causal mechanism in the development of depressive symptomatology (Dantzer et al., 2008; DellaGioia and Hannestad, 2010; Miller et al., 2009 ). Pro-inflammatory cytokines, such as interleukin (IL)-1b, IL-6 and Tumor Necrosis Factor alpha (TNF-a), are known to induce sickness behavior, a set of behavior changes that overlap with depressive symptomatology (e.g., fatigue, social withdrawal, loss of interest) (Dantzer et al., 2008) . A number of studies have found that patients with depressive disorders have a heightened pro-inflammatory milieu relative to controls (Dhabhar et al., 2009; Maes et al., 1997; Thomas et al., 2005) . These elevations persist after antidepressant treatment
